Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP plus triamcinolone versus saline for olfactory dysfunction after endoscopic sinus surgery in nasal polyposis
IRCT20230127057244N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of triamcinolone and platelet-rich plasma in rhinosinusitis and chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: olfactory changes. Started Jan 2025; status: completed.
02
Drugs
triamcinoloneplatelet-rich plasma
03
Conditions
rhinosinusitischronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on IRCT20230127057244N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230127057244N2.